{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:45:20Z","timestamp":1786405520564,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/pas.0b013e3182753f5a","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T19:12:54Z","timestamp":1354648374000},"page":"89-97","source":"Crossref","is-referenced-by-count":31,"title":["Stathmin-1 Expression as a Complement to p16 Helps Identify High-grade Cervical Intraepithelial Neoplasia With Increased Specificity"],"prefix":"10.1097","volume":"37","author":[{"given":"Brooke E.","family":"Howitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2009.05.046","article-title":"Value of p16(INK4a) as a marker of progressionregression in cervical intraepithelial neoplasia grade 1.","volume":"201","author":"del Pino","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/0DGGQBDQAMJCJBXB","article-title":"The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.","volume":"122","author":"Guo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/PGP.0b013e31821ac4fd","article-title":"Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.","volume":"30","author":"Gatta","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0028-2243(95)02303-A","article-title":"Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV).","volume":"65","author":"Syrjanen","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2009.04.011","article-title":"The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.","volume":"145","author":"Kim","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00432-008-0520-1","article-title":"Expression of stathminop18 as a significant prognostic factor for cervical carcinoma patients.","volume":"135","author":"Xi","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3109\/07357900009012204","article-title":"The phosphoprotein Op18stathmin is differentially expressed in ovarian cancer.","volume":"18","author":"Price","year":"2000","journal-title":"Cancer Invest"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cncr.24282","article-title":"Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.","volume":"115","author":"Su","year":"2009","journal-title":"Cancer"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.acthis.2007.06.002","article-title":"Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma.","volume":"110","author":"Wei","year":"2008","journal-title":"Acta Histochem"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.0806514106","article-title":"Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.","volume":"106","author":"Salvesen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2559.2010.03661.x","article-title":"Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.","volume":"57","author":"Trovik","year":"2010","journal-title":"Histopathology"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-10-2412","article-title":"Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.","volume":"17","author":"Trovik","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/bjc.1998.565","article-title":"Overexpression of the stathmin gene in a subset of human breast cancer.","volume":"78","author":"Bieche","year":"1998","journal-title":"Br J Cancer"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/bjoc.2000.1264","article-title":"Correlation of oncoprotein 18stathmin expression in human breast cancer with established prognostic factors.","volume":"83","author":"Brattsand","year":"2000","journal-title":"Br J Cancer"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1054\/bjoc.1999.0891","article-title":"Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.","volume":"82","author":"Curmi","year":"2000","journal-title":"Br J Cancer"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-007-9724-3","article-title":"The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.","volume":"110","author":"Golouh","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.bjc.6605537","article-title":"Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.","volume":"102","author":"Jeon","year":"2010","journal-title":"Br J Cancer"},{"key":"R20-11-20210131","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/pr2010956","article-title":"Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.","volume":"11","author":"Tan","year":"2012","journal-title":"J Proteome Res"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/pr100712t","article-title":"Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.","volume":"9","author":"Zheng","year":"2010","journal-title":"J Proteome Res"},{"key":"R22-11-20210131","first-page":"1037","article-title":"Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.","volume":"23","author":"Gan","year":"2010","journal-title":"Oncol Rep"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/mc.20627","article-title":"Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma.","volume":"49","author":"Hsieh","year":"2010","journal-title":"Mol Carcinog"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.21736","article-title":"Protumorigenic overexpression of stathminOp18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.","volume":"46","author":"Singer","year":"2007","journal-title":"Hepatology"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1074\/mcp.M200055-MCP200","article-title":"Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.","volume":"2","author":"Chen","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"R26-11-20210131","first-page":"39","article-title":"Stathmin is overexpressed in malignant mesothelioma.","volume":"27","author":"Kim","year":"2007","journal-title":"Anticancer Res"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10238-009-0068-7","article-title":"Hedgehog signaling regulates proliferation of prostate cancer cells via stathmin1.","volume":"10","author":"Chung","year":"2010","journal-title":"Clin Exp Med"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pros.20601","article-title":"Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression.","volume":"67","author":"Ghosh","year":"2007","journal-title":"Prostate"},{"key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1517\/14728222.2011.620951","article-title":"Stathmin: a protein with many tasks. New biomarker and potential target in cancer.","volume":"15","author":"Belletti","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"R30-11-20210131","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.urology.2009.04.088","article-title":"Expression of stathmin in localized upper urinary tract urothelial carcinoma: correlations with prognosis.","volume":"74","author":"Lin","year":"2009","journal-title":"Urology"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0029-1202789","article-title":"Stathmin as a marker for malignancy in pheochromocytomas.","volume":"118","author":"Bjorklund","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R32-11-20210131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjc.6602991","article-title":"Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis.","volume":"94","author":"Kouzu","year":"2006","journal-title":"Br J Cancer"},{"key":"R33-11-20210131","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3171\/2009.2.PEDS08287","article-title":"High expression of stathmin protein predicts a fulminant course in medulloblastoma.","volume":"4","author":"Kuo","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"R34-11-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1015-9584(11)60013-4","article-title":"Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.","volume":"34","author":"Lin","year":"2011","journal-title":"Asian J Surg"},{"key":"R35-11-20210131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ijc.21318","article-title":"Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands.","volume":"118","author":"Nakashima","year":"2006","journal-title":"Int J Cancer"},{"key":"R36-11-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12022-008-9028-0","article-title":"Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.","volume":"19","author":"Sadow","year":"2008","journal-title":"Endocr Pathol"},{"key":"R37-11-20210131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jso.21870","article-title":"Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma.","volume":"103","author":"Wang","year":"2011","journal-title":"J Surg Oncol"},{"key":"R38-11-20210131","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1535-7163.MCT-05-0215","article-title":"Targeting stathmin in prostate cancer.","volume":"4","author":"Mistry","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"R40-11-20210131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R41-11-20210131","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4161\/cbt.9.9.11442","article-title":"High-risk human papillomavirus type 18 E7 caused p27 elevation and cytoplasmic localization.","volume":"9","author":"Yan","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"R42-11-20210131","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R44-11-20210131","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using biomarkers as objective standards in the diagnosis of cervical biopsies.","volume":"34","author":"Galgano","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R45-11-20210131","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/00000478-200107000-00006","article-title":"Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.","volume":"25","author":"Keating","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R48-11-20210131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mpdhp.2010.06.012","article-title":"Molecular markers of early cervical neoplasia.","volume":"16","author":"Pinto","year":"2011","journal-title":"Diagn Histopathol (Oxf)"},{"key":"R50-11-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pgp.0000236942.51840.56","article-title":"The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix.","volume":"26","author":"Hariri","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R51-11-20210131","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.humpath.2010.10.021","article-title":"Biomarker expression in cervical intraepithelial neoplasia: potential progression predictive factors for low-grade lesions.","volume":"42","author":"Ozaki","year":"2011","journal-title":"Hum Pathol"},{"key":"R52-11-20210131","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1091\/mbc.e07-09-0894","article-title":"Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.","volume":"19","author":"Belletti","year":"2008","journal-title":"Mol Biol Cell"},{"key":"R55-11-20210131","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1002\/1097-0142(20011215)92:12<3005::AID-CNCR10153>3.0.CO;2-6","article-title":"Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1).","volume":"92","author":"Shiozawa","year":"2001","journal-title":"Cancer"},{"key":"R56-11-20210131","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/sj.onc.1202549","article-title":"Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.","volume":"18","author":"Zehbe","year":"1999","journal-title":"Oncogene"},{"key":"R57-11-20210131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/modpathol.2010.85","article-title":"Histological progression from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review.","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-201301000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:32:28Z","timestamp":1618036348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201301000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3182753f5a","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}